Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

This international, multicentre, observational cohort study describes management of critically ill CAR T-cell recipients in 21 ICUs in France, Spain, the US, UK, Russia, Canada, Germany, and Austria (n=942). The primary endpoint of 90-day mortality was 22·4% (54 deaths).

The Lancet Haematology